On February 5, Adisseo (600299.SH) released its performance forecast for 2024. The company saw a yearly revenue?of 15.53 billion yuan, marking an 18%?year-on-year increase. Gross profit reached 4.69 billion yuan, representing a 67% year-on-year growth, with a net profit of 1.2 billion yuan.

In 2024, by tapping into the worldwide industrial setup, Adisseo consistently introduced innovative products and services, and tailored solutions for various markets, further solidifying its leading position. With efficient and steady production capacity and adaptable supply chain management, Adisseo's methionine?business overcame challenges like rising raw material prices, achieving a 24% year-on-year increase in sales revenue and a significant boost in gross profit margin.

The successful implementation?of Adisseo's "One-China Strategy" led to record-high sales of liquid methionine in the Chinese market, while customized aquatic product solutions drove robust sales growth locally. The recovery of vitamin prices at the end of 2024 also contributed to the company's performance. Despite obstacles in the dairy industry, Adisseo's specialty product division achieved a 4% growth, with a 9%?year-on-year increase in gross profit. Notably, ruminant animal products set?a single-month record in December 2024.

Safety management has always been the core of Adisseo's steady development. In 2024, the company's total recordable incident rate (TRIR) was 0.10, reaching its best level?in history. In 2024, Adisseo entered its sixth year of cost-saving efforts, further advancing operational efficiency improvement plans and successfully optimizing its organizational structure, digital control, and global supply chain layout.